AI assistant
Sending…
Abliva — Major Shareholding Notification 2014
Apr 4, 2014
3131_iss_2014-04-04_536bc2d8-6809-49ec-9ea5-f91c485e977c.pdf
Major Shareholding Notification
Open in viewerOpens in your device viewer
Issuer Abliva AB
Holder
Maas Biolab, LLC
Instrument
| Instrument | Common |
|---|---|
| Before the transaction | |
| Shares | 4,233,736 |
| Voting rights | 4,233,736 |
| Transaction | |
| Reason for major shareholding notification Sell | |
| Date | 31/03/2014 |
| Limit for number of shares | 15 % |
| Limit for number of votes | 15 % |
| After the transaction | |
| Quantity | |
| Shares | 3,874,432 |
| Directly held voting rights | 3,874,432 |
| Indirectly held voting rights | 0 |
| Percentage | |
| Directly held shares | 13.9499 % |
| Directly held voting rights | 13.9499 % |
| Indirectly held voting rights | 0 % |
Resulting distribution of total holdings
| Percentage of voting rights: |
Number of underlying shares: |
|
|---|---|---|
| Shares | ||
| Instruments - FITA Ch. 4, section 2, first |
paragraph, line 2 Instruments - FITA Ch. 4, section 2, first paragraph, line 3
-
Physically settled
-
Cash settled
Total
Group total holdings
Voting rights 3,874,432 Percentage of voting rights 13.9499
Notes (other relevant informations according to law)
Correction of previous notification. The correct number of NVP shares remaining in Maas Biolab is 3 874 432 and not 3 864 432.
Published
04/04/2014 08:55
Contact
Name Marcus Keep
Phone +1 (505) 288-8897 Email [email protected]
[email protected] Tfn 08-408 980 37 Fax 08-24 39 25
More from Abliva
Delisting Announcement
2025
Mar 3
Delisting Announcement
2025
Mar 3
AGM Information
2025
Feb 26
AGM Information
2025
Feb 26
Delisting Announcement
2025
Feb 25
Delisting Announcement
2025
Feb 25
Declaration of Voting Results & Voting Rights Announcements
2025
Feb 21
Interim / Quarterly Report
2025
Feb 21
Interim / Quarterly Report
2025
Feb 21
Major Shareholding Notification
2025
Feb 12